Liquid chromatography - high resolution mass spectrometry-based metabolomic approach for the detection of Continuous Erythropoiesis Receptor Activator effects in horse doping control.

Erythropoiesis Stimulating Agents (ESAs) were developed for therapeutic purposes to stimulate red blood cell (RBC) production. Consequently, tissue oxygenation is enhanced as athlete's endurance and ESAs misuse now benefits doping. Our hypothesis is that most of ESAs should have similar mechanisms and thus have the same effects on metabolism.

Segmental bioelectrical impedance analysis (SBIA) and blood rheology: Reducing the gap between in vivo and in vitro?

Bioelectrical impedancemetry (BIA) has been used to evaluate hematocrit and red cell aggregability in vitro but whole body impedance measurements are also correlated to some hemorheologic factors, suggesting a relationship between viscosity factors and electric properties of blood. We repeatedly reported correlations with whole body BIA and hematocrit, whole blood viscosity and plasma viscosity, red cell rigidity and RBC aggregation. The SBIA Inbody 770 modelizes body as 5 cylinders and measures impedance at 1, 5, 50, 250, 500, and 1000 kHz.

Rise in RBC aggregability and concomitant decrease in blood pressure 10 days after injection of the long acting erythropoietin analogue methoxy polyethylene glycol-epoetin-β (MIRCERA®).

Erythropoietin (EPO) is a major regulator of blood viscosity. Its long lasting action analogue methoxy polyethylene glycol-epoetin-β (MIRCERA®) seems to be also employed in modern doping. We took the opportunity of a study aiming at developing a detection of recent MIRCERATM injection in the context of doping detection to assess the effects of this EPO analogue on red blood cells (RBC) aggregation.